CYP‐mediated drug metabolism in the brain impacts drug response

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Pharmacology and Therapeutics

• Publication date

  2017-10-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.pharmthera.2017.10.008PMID 29024742
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target

  2017cited by this paper
• Inducing rat brain CYP2D with nicotine increases the rate of codeine tolerance; predicting the rate of tolerance from acute analgesic response

  2017cited by this paper
• Glutamate affects the production of epoxyeicosanoids within the brain: The up-regulation of brain CYP2J through the MAPK-CREB signaling pathway.

  2017cited by this paper
• Rat brain CYP2D enzymatic metabolism alters acute and chronic haloperidol side‐effects by different mechanisms

  2017cited by this paper
• Brain CYP2B induction can decrease nicotine levels in the brain

  2017cited by this paper
• Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment

  2017cited by this paper
• The induction of cytochrome P450 2E1 by ethanol leads to the loss of synaptic proteins via PPARα down-regulation.

  2017cited by this paper
• Upregulation of 20-HETE Synthetic Cytochrome P450 Isoforms by Oxygen–Glucose Deprivation in Cortical Neurons

  2017cited by this paper
• Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment

  2017cited by this paper
• The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the Brain

  2017cited by this paper
• Emerging roles for brain drug-metabolizing cytochrome P450 enzymes in neuropsychiatric conditions and responses to drugs

  2016cited by this paper
• Melatonin Supports CYP2D-Mediated Serotonin Synthesis in the Brain

  2016cited by this paper
• The cytochrome P450 2D‐mediated formation of serotonin from 5‐methoxytryptamine in the brain in vivo: a microdialysis study

  2015cited by this paper
• Sex hormones regulate cerebral drug metabolism via brain miRNAs: down‐regulation of brain CYP2D by androgens reduces the analgesic effects of tramadol

  2015cited by this paper
• Gene expression profiling of cytochromes P450, ABC transporters and their principal transcription factors in the amygdala and prefrontal cortex of alcoholics, smokers and drug-free controls by qRT-PCR

  2015cited by this paper
• Neuronal cytochrome P450 activity and opioid analgesia: relevant sites and mechanisms.

  2015cited by this paper
• Nicotine Increases Codeine Analgesia Through the Induction of Brain CYP2D and Central Activation of Codeine to Morphine

  2015cited by this paper
• Regulation of cerebral CYP2D alters tramadol metabolism in the brain: interactions of tramadol with propranolol and nicotine

  2015cited by this paper
• Effect of Brain CYP2B Inhibition on Brain Nicotine Levels and Nicotine Self-Administration

  2015cited by this paper
• Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials

  2015cited by this paper
• Ethanol self‐administration and nicotine treatment increase brain levels of CYP2D in African green monkeys

  2014cited by this paper
• CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials.

  2014cited by this paper
• Cytochrome P450 mRNA Expression in the Rodent Brain: Species-, Sex-, and Region-Dependent Differences

  2014cited by this paper
• Deficits in neuronal cytochrome P450 activity attenuate opioid analgesia but not opioid side effects.

  2014cited by this paper
• Effect of status epilepticus and antiepileptic drugs on CYP2E1 brain expression.

  2014cited by this paper
• Significance of neuronal cytochrome P450 activity in opioid-mediated stress-induced analgesia.

  2014cited by this paper
• Intracerebroventricularly and systemically delivered inhibitor of brain CYP2B (C8-Xanthate), even following chlorpyrifos exposure, reduces chlorpyrifos activation and toxicity in male rats.

  2014cited by this paper
• The endogenous substrates of brain CYP2D.

  2014cited by this paper
• Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function

  2013cited by this paper
• Decreased hippocampal volume and increased anxiety in a transgenic mouse model expressing the human CYP2C19 gene

  2013cited by this paper
• Ethanol self-administration and nicotine treatment induce brain levels of CYP2B6 and CYP2E1 in African green monkeys.

  2013cited by this paper
• Potential role of CYP2D6 in the central nervous system

  2013cited by this paper
• The catalytic competence of cytochrome P450 in the synthesis of serotonin from 5-methoxytryptamine in the brain: an in vitro study.

  2013cited by this paper
• First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivo.

  2013cited by this paper
• Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.

  2013cited by this paper
• Cytochrome P450-mediated drug metabolism in the brain.

  2013cited by this paper
• Induction of brain CYP2E1 by chronic ethanol treatment and related oxidative stress in hippocampus, cerebellum, and brainstem.

  2012cited by this paper
• Dysfunctional hippocampal activity affects emotion and cognition in mood disorders.

  2012cited by this paper
• Differential Effects of Nicotine Treatment and Ethanol Self-Administration on CYP2A6, CYP2B6 and Nicotine Pharmacokinetics in African Green Monkeys

  2012cited by this paper
• The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients.

  2012cited by this paper
• Rat brain CYP2B-enzymatic activation of chlorpyrifos to the oxon mediates cholinergic neurotoxicity.

  2012cited by this paper
• Genetic variation in CYP2D6 impacts neural activation during cognitive tasks in humans

  2012cited by this paper
• CYP2D6 in the brain: genotype effects on resting brain perfusion

  2011cited by this paper
• Cytochrome P450 mediates dopamine formation in the brain in vivo

  2011cited by this paper
• Hormonal and reproductive disturbances in epileptic male patients: emerging issues.

  2011cited by this paper
• The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain.

  2011cited by this paper
• The Metabolism of Opioid Agents and the Clinical Impact of Their Active Metabolites

  2011cited by this paper
• Non-coding RNAs in human disease

  2011cited by this paper
• Drug Metabolism within the Brain Changes Drug Response: Selective Manipulation of Brain CYP2B Alters Propofol Effects

  2011cited by this paper
• Role of retinoids, rexinoids and thyroid hormone in the expression of cytochrome p450 enzymes.

  2011cited by this paper
• Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesic

  2011cited by this paper
• Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier.

  2011cited by this paper
• Independent and Combined Effects of Ethanol Self-Administration and Nicotine Treatment on Hepatic CYP2E1 in African Green Monkeys

  2011cited by this paper
• Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids

  2010cited by this paper
• Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism.

  2010cited by this paper
• Epoxyeicosanoid signaling in CNS function and disease.

  2010cited by this paper
• Rat brain CYP2B induction by nicotine is persistent and does not involve nicotinic acetylcholine receptors.

  2010cited by this paper
• The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study.

  2010cited by this paper
• Opioids Activate Brain Analgesic Circuits Through Cytochrome P450/Epoxygenase Signaling

  2010cited by this paper
• Association between CYP2C19 polymorphism and depressive symptoms

  2010cited by this paper
• Cytochrome P450 2D6 enzyme neuroprotects against 1‐methyl‐4‐phenylpyridinium toxicity in SH‐SY5Y neuronal cells

  2010cited by this paper
• Nuclear Receptor Coactivators: Essential Players for Steroid Hormone Action in the Brain and in Behaviour

  2009cited by this paper
• Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes

  2009cited by this paper
• Xenobiotic-Metabolizing Enzymes and Transporters in the Normal Human Brain: Regional and Cellular Mapping as a Basis for Putative Roles in Cerebral Function

  2009cited by this paper
• Arachidonic acid cytochrome P450 epoxygenase pathway Work from my laboratory cited in this review was supported by National Institutes of Health grants HL049264 and HL072845. Published, JLR Papers in Press, October 23, 2008.

  2009cited by this paper
• Functional implications of genetic variation in human PPARgamma.

  2009cited by this paper
• Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake.

  2009cited by this paper
• Modulation of androgen and estrogen receptor expression by antiepileptic drugs and steroids in hippocampus of patients with temporal lobe epilepsy

  2009cited by this paper
• Multiple roles for nicotine in Parkinson's disease.

  2009cited by this paper
• Brain Drug-Metabolizing Cytochrome P450 Enzymes are Active In Vivo, Demonstrated by Mechanism-Based Enzyme Inhibition

  2009cited by this paper
• ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood–brain barrier

  2008cited by this paper
• Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment.

  2008cited by this paper
• Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide

  2008cited by this paper
• Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.

  2008cited by this paper
• Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.

  2007cited by this paper
• shRNA and siRNA delivery to the brain.

  2007cited by this paper
• The regulation of liver cytochrome p450 by the brain dopaminergic system.

  2007cited by this paper
• Expression and function of cytochrome p450 in brain drug metabolism.

  2007cited by this paper
• CYP2B6 is expressed in African Green monkey brain and is induced by chronic nicotine treatment.

  2006cited by this paper
• INDUCTION AND RECOVERY TIME COURSE OF RAT BRAIN CYP2E1 AFTER NICOTINE TREATMENT

  2006cited by this paper
• In Vivo and in Vitro Characterization of Chlorzoxazone Metabolism and Hepatic CYP2E1 Levels in African Green Monkeys: Induction by Chronic Nicotine Treatment

  2006cited by this paper
• Quantification of the expression and inducibility of 12 rat cytochrome P450 isoforms by quantitative RT–PCR

  2006cited by this paper
• Anti‐epileptic drug phenytoin enhances androgen metabolism and androgen receptor expression in murine hippocampus

  2006cited by this paper
• Growth hormone regulation of sex-dependent liver gene expression.

  2006cited by this paper
• Phenobarbital increases monkey in vivo nicotine disposition and induces liver and brain CYP2B6 protein

  2006cited by this paper
• CYP1A in TCDD Toxicity and in Physiology–with Particular Reference to CYP Dependent Arachidonic Acid Metabolism and other Endogenous Substrates

  2006cited by this paper
• Nicotine induces brain CYP enzymes: relevance to Parkinson's disease.

  2006cited by this paper
• Phenobarbital induces monkey brain CYP2E1 protein but not hepatic CYP2E1, in vitro or in vivo chlorzoxazone metabolism.

  2006cited by this paper
• Regional and cellular distribution of CYP2E1 in monkey brain and its induction by chronic nicotine.

  2006cited by this paper
• Genetic variants of PXR (NR1I2) and CAR (NR1I3) and their implications in drug metabolism and pharmacogenetics.

  2005cited by this paper
• HUMAN CYP2D6 AND MOUSE CYP2DS: ORGAN DISTRIBUTION IN A HUMANIZED MOUSE MODEL

  2005cited by this paper
• Effect of Antiepileptic Drugs on Reproductive Endocrine Function in Individuals with Epilepsy

  2005cited by this paper
• Influence of age and gender on risperidone plasma concentrations

  2005cited by this paper
• FUNCTIONAL ANALYSIS OF SIX HUMAN ARYL HYDROCARBON RECEPTOR VARIANTS IN A JAPANESE POPULATION

  2005cited by this paper
• Anxiety in patients with epilepsy: systematic review and suggestions for clinical management.

  2005cited by this paper
• CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease

  2004cited by this paper
• Cigarette smoking in Parkinson's disease: Influence on disease progression

  2004cited by this paper
• The effect of quinidine on the analgesic effect of codeine

  2004cited by this paper
• Expression of Constitutive Androstane Receptor Splice Variants in Human Tissues and Their Functional Consequences

  2004cited by this paper
• Nicotine coregulates multiple pathways involved in protein modification/degradation in rat brain.

  2004cited by this paper

• Pharmacokinetics of Midazolam in Plasma and Brain Tissue of Rats after Exposure to Acute and Chronic High Altitude Hypoxia

  2025cites this paper
• Differential long-term effects of physical, social, and psychological stressors in male mice: down-regulation of inflammatory markers and unresponsiveness of the antioxidant system.

  2025cites this paper
• Blood-brain barriers and drug pharmacokinetics: mechanisms and models.

  2025cites this paper
• The effect of prolonged treatment with antipsychotic drugs on cytochrome P450 − drug metabolizing enzymes. Mechanisms of action and significance for pharmacotherapy

  2025cites this paper
• Association between drug-induced heart failure and CYP1A1, CYP1B1, and CYP3A4 inhibition: Utility of cytochrome P450 inhibition assay for evaluating cardiotoxicity of drug candidates.

  2025cites this paper
• Validation studies and multiomics analysis of Zhx2 as a candidate quantitative trait gene underlying brain oxycodone metabolite (oxymorphone) levels and behavior.

  2025cites this paper
• Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation

  2025cites this paper
• Validation studies and multi-omics analysis of Zhx2 as a candidate quantitative trait gene underlying brain oxycodone metabolite (oxymorphone) levels and behavior

  2024cites this paper
• Human CYP2D6 varies across the estrous cycle in brains of transgenic mice altering drug response.

  2024cites this paper
• The Effect of Maternal High-Fat or High-Carbohydrate Diet during Pregnancy and Lactation on Cytochrome P450 2D (CYP2D) in the Liver and Brain of Rat Offspring

  2024cites this paper
• Exploring the Regulation of Cytochrome P450 in SH-SY5Y Cells: Implications for the Onset of Neurodegenerative Diseases

  2024cites this paper
• Clozapine treatment and astrocyte activity in treatment resistant schizophrenia: A proton magnetic resonance spectroscopy study.

  2024cites this paper
• Exploring Kp,uu,BBB Values Smaller than Unity in Remoxipride: A Physiologically-Based CNS Model Approach Highlighting Brain Metabolism in Drugs with Passive Blood-Brain Barrier Transport

  2024cites this paper
• Inhibition of Human CYP1A1/A2 by a Hydroalcoholic Extract and Its Neolignan Constituents from Piperrivinoides

  2024cites this paper
• A multi-ancestry cerebral cortex transcriptome-wide association study identifies genes associated with smoking behaviors

  2024cites this paper
• Genetic background and sex influence somatosensory sensitivity and oxycodone analgesia in the Hybrid Rat Diversity Panel

  2024cites this paper
• Biochemical Mechanisms in Drug Metabolism: Implications for Personalized Pharmacotherapy in Pharmacy Practice

  2024cites this paper
• Role of Redox Homeostasis in the Communication Between Brain and Liver Through Extracellular Vesicles

  2024cites this paper
• LY354740, an agonist of glutamatergic metabotropic receptor mGlu2/3 increases the cytochrome P450 2D (CYP2D) activity in the frontal cortical area of rat brain

  2024cites this paper
• Interactions of Polychlorinated Biphenyls and Their Metabolites with the Brain and Liver Transcriptome of Female Mice

  2024cites this paper
• Jiawei Xionggui Decoction promotes meningeal lymphatic vessels clearance of β-amyloid by inhibiting arachidonic acid pathway.

  2024cites this paper
• Characterization of the Stereoselective Disposition of Bupropion and Its Metabolites in Rat Plasma and Brain

  2023cites this paper
• Métabolisme des xénobiotiques

  2023cites this paper
• The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure

  2023cites this paper
• Genetic polymorphisms of very important pharmacogene variants in the Chinese Lisu population.

  2023cites this paper
• Intrathecal delivery of Macromolecules: Clinical status and emerging technologies.

  2023cites this paper
• Identification of Cytochrome P450 2E1 as a Novel Target in Glioma and Development of Its Inhibitor as an Anti‐Tumor Agent

  2023cites this paper
• Extracellular vesicles: Critical bilateral communicators in periphery-brain crosstalk in central nervous system disorders.

  2023cites this paper
• The mechanisms of interactions of psychotropic drugs with liver and brain cytochrome P450 and their significance for drug effect and drug-drug interactions.

  2022cites this paper
• Aryl Hydrocarbon Receptor (AhR)-Mediated Signaling in iPSC-Derived Human Motor Neurons

  2022cites this paper
• Tobacco consumption during the COVID-19 pandemic and pharmacokinetic interaction involving cytochrome P-450 with psychoactive drugs: an integrative review

  2022cites this paper
• Hepatic, Extrahepatic and Extracellular Vesicle Cytochrome P450 2E1 in Alcohol and Acetaminophen-Mediated Adverse Interactions and Potential Treatment Options

  2022cites this paper
• Common insecticide affects spatial navigation in bats at environmentally-realistic doses

  2022cites this paper
• Differential expression and activities of cytochrome P450 3A in the rat brain microsomes and mitochondria

  2022cites this paper
• The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia

  2022influential citation
• The Effect of the Selective N-methyl-D-aspartate (NMDA) Receptor GluN2B Subunit Antagonist CP-101,606 on Cytochrome P450 2D (CYP2D) Expression and Activity in the Rat Liver and Brain

  2022cites this paper
• Mental Performance and Sport: Caffeine and Co-consumed Bioactive Ingredients

  2022cites this paper
• The role of brain barriers in the neurokinetics and pharmacodynamics of lithium.

  2021cites this paper
• Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms

  2021cites this paper
• Cytochrome P450 Enzymes and Drug Metabolism in Humans

  2021cites this paper
• Cytochrome P450 2D (CYP2D) enzyme dysfunction associated with aging and serotonin deficiency in the brain and liver of female Dark Agouti rats.

  2021cites this paper
• Chronic treatment with asenapine affects cytochrome P450 2D (CYP2D) in rat brain and liver. Pharmacological aspects.

  2021cites this paper
• The role of efflux transporters and metabolizing enzymes in brain and peripheral organs to explain drug‐resistant epilepsy

  2021cites this paper
• Safety and Drug Metabolism: Toward NCE and First in Human

  2021cites this paper
• Pharmacogenomics: A road ahead for precision medicine in psychiatry

  2021cites this paper
• Insights into the effects of difenoconazole on the livers in male mice at the biochemical and transcriptomic levels.

  2021cites this paper
• UPLC-MS/MS analysis of the Michaelis-Menten kinetics of CYP3A-mediated midazolam 1'- and 4-hydroxylation in rat brain microsomes.

  2021cites this paper
• Xenobiotic Transport and Metabolism in the Human Brain.

  2021cites this paper
• Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation

  2021cites this paper
• Diesel exhaust exposure alters the expression of networks implicated in neurodegeneration in zebrafish brains

  2021cites this paper
• MAM-2201, One of the Most Potent—Naphthoyl Indole Derivative—Synthetic Cannabinoids, Exerts Toxic Effects on Human Cell-Based Models of Neurons and Astrocytes

  2021cites this paper
• Alterations of Cytochrome P450s and UDP-Glucuronosyltransferases in Brain Under Diseases and Their Clinical Significances

  2021cites this paper
• Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes

  2021cites this paper
• Prediction of the dose range for adverse neurological effects of amiodarone in patients from an in vitro toxicity test by in vitro–in vivo extrapolation

  2021cites this paper
• Comparative Metabolism of Gelsenicine in Liver Microsomes from Humans, Pigs, Goats and Rats.

  2020cites this paper
• Cytochrome P450 expression and regulation in the brain

  2020cites this paper
• Oxycodone in the Opioid Epidemic: High ‘Liking’, ‘Wanting’, and Abuse Liability

  2020cites this paper
• Centrally administered CYP2D inhibitors increase oral tramadol analgesia in rats.

  2020cites this paper
• β-Naphthoflavone and Ethanol Reverse Mitochondrial Dysfunction in A Parkinsonian Model of Neurodegeneration

  2020influential citation
• Ketamine’s pharmacogenomic network in human brain contains sub-networks associated with glutamate neurotransmission and with neuroplasticity

  2020cites this paper
• Analgesic efficacy and pharmacokinetics of epidural oxycodone in pain management after gynaecological laparoscopy—A randomised, double blind, active control, double‐dummy clinical comparison with intravenous administration

  2019cites this paper
• Updated Clinical Pharmacokinetics and Pharmacodynamics of Oxycodone

  2019cites this paper
• Kinetics of dextromethorphan-O-demethylase activity and distribution of CYP2D in four commonly-used subcellular fractions of rat brain

  2019cites this paper
• Circulating Extracellular Vesicles Containing Xenobiotic Metabolizing CYP Enzymes and Their Potential Roles in Extrahepatic Cells Via Cell–Cell Interactions

  2019cites this paper
• Mental energy: plausible neurological mechanisms and emerging research on the effects of natural dietary compounds

  2019cites this paper
• Oxycodone concentrations in the central nervous system and cerebrospinal fluid after epidural administration to the pregnant ewe

  2019cites this paper
• The need for mathematical modelling of spatial drug distribution within the brain

  2019cites this paper
• Relationship between the hippocampal expression of selected cytochrome P450 isoforms and the animal performance in the hippocampus-dependent learning task.

  2018cites this paper
• Stat5b Regulates Sexually Dimorphic Gene Expression in Zebrafish Liver

  2018cites this paper
• UPLC-MS/MS analysis of dextromethorphan-O-demethylation kinetics in rat brain microsomes.

  2018cites this paper
• The activity of brain and liver cytochrome P450 2D (CYP2D) is differently affected by antidepressants in the chronic mild stress (CMS) model of depression in the rat

  2018cites this paper
• The engagement of brain cytochrome P450 in the metabolism of endogenous neuroactive substrates: a possible role in mental disorders

  2018cites this paper
• Pharmacoresistant Severe Mental Health Disorders in Children and Adolescents: Functional Abnormalities of Cytochrome P450 2D6

  2018cites this paper